Scott S. Zamvil, MD, PhD corresponding author and Anthony J. Slavin, PhD
From the Department of Neurology and Program in Immunology (S.S.Z.), University of California, San Francisco; and Abbvie Bioresearch Center Inc. (A.J.S.), Worcester, MA.
Corresponding author.
Correspondence to Dr. Zamvil: gro.lonummioruen.fscu@livmaz
While neuromyelitis optica (NMO) immunoglobulin (Ig) G is considered the hallmark serologic marker of NMO, its association is not absolute, as NMO IgG is not detected in approximately one-fourth of the patients diagnosed with NMO spectrum disorder (NMOSD). Thus, the recent discovery that antibodies to myelin oligodendrocyte glycoprotein (MOG) are detected in some NMO IgG-seronegative patients manifesting clinical and neuroimaging signs of NMO or NMOSD has created tremendous excitement. However, it may be premature to classify this subgroup as NMOSD. NMO is considered an autoimmune astrocytopathy, and aquaporin-4 (AQP4), expressed on astrocytes, is recognized as the target autoantigen of NMO IgG. As its name denotes, MOG is produced by oligodendrocytes, CNS myelin-producing cells, and MOG is well-recognized as one of the candidate autoantigens in multiple sclerosis (MS) and acute disseminated encephalomyelitis (ADEM). Thus, is it possible that the clinical NMOSD-like phenotype associated with MOG-specific antibodies represents a variant of opticospinal MS or ADEM but not AQP4 autoimmunity or NMOSD? Whether this MOG-Ig positive AQP4-seronegative phenotype should be classified as NMOSD, opticospinal MS, or a unique entity is not simply a theoretical question but rather has practical implications for patients, their physicians, insurance carriers, and clinical investigators conducting NMO treatment trials.
Continued at source.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309526/
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Jump to
- What is NMO
- Category: Diagnosis
- ↳ Forum: Signs and Symptoms
- ↳ Forum: International consensus diagnostic criteria
- ↳ Forum: Anti-Mog
- NMO in the news
- Category: Attacks
- ↳ Forum: Real Attacks
- ↳ Forum: Pseudo Flares
- ↳ Forum: Brain and Brain Stem
- ↳ Forum: Optic neuritis
- ↳ Forum: Transverse Myelitis (TM) and Longitudinally Extensive Transverse Myelitis (LETM)
- Category: Treatments
- ↳ Sub Category: Acute Attacks
- ↳ IVSM
- ↳ IVIG
- ↳ Plasmapheresis (Plex)
- ↳ Sub Category: Preventative
- ↳ Imuran (Azathioprine)
- ↳ CellCept
- ↳ Rituxan
- ↳ Soliris
- ↳ Actemra
- ↳ Sub Category: Spasms
- ↳ Tizanidine
- ↳ Baclofen
- ↳ Holistics
- ↳ Cannabis
- ↳ Tegretol
- ↳ Sub Category: Health/Diet
- ↳ Wahls Protocol
- ↳ Paleo Diet
- ↳ Oils
- ↳ Gluten free
- ↳ Vitamins
- ↳ China Study
- ↳ Clinical Research
- Category: Stories of NMO
- ↳ Forum: Share your Story
- Category: Support
- ↳ Forum: Kids with NMO (Pediatric)
- ↳ Forum: Teens with NMO
- ↳ Forum: Caregivers
- ↳ Forum: Coping with Diagnosis
- ↳ Forum: Patients
- ↳ Forum: Depression and Mental Health
- ↳ Sub Category: Insurance
- ↳ Forum: Service and Guide Dogs
- ↳ Forum: Companion and Support Dogs
- ↳ Forum: Events
- ↳ Forum: Facebook Groups and pages
- ↳ Forum: Advocacy
- ↳ Forum: Connecting one another
- Category: Pregnancy
- ↳ Forum: Getting Pregnant
- ↳ Forum: During Pregnancy
- ↳ Forum: After Pregnancy
- ↳ Effectiveness and safety of immunosuppressive therapy in neuromyelitis optica spectrum disorder during pregnancy.
- Category: Common Issues and Concerns
- ↳ Forum: Bladder Issues
- ↳ Forum: Bowel Issues
- ↳ Forum: Catheters
- ↳ Forum: Menstrual cycles
- ↳ Forum: Urinary tract infections (UTI)
- Category: Sexual intimacy
- ↳ Forum: Males with NMO
- ↳ Forum: Females with NMO
- Category: Disabilities
- ↳ Forum: Vision Loss
- ↳ Forum: Wheelchair-bound
- ↳ Forum: Paralysis
- Category: Reviews
- ↳ Forum: Doctors
- ↳ Forum: Hospitals
- ↳ Forum: Assistant Devices
- Category: NMO Chat Administration
- ↳ Forum: Forum Suggestions
- ↳ Forum: Moderator Assistance Request
- ↳ Forum: Trouble Tickets